Tumor lysis syndrome
Billable / specific
E88.3 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.
Inclusion terms
Applicable to
- Tumor lysis syndrome (spontaneous)
- Tumor lysis syndrome following antineoplastic drug chemotherapy
Includes (from E88)
- Note: All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Excludes1
Not coded here — never report together with this code.
- transitory endocrine and metabolic disorders specific to newborn (P70-P74) (from E88)
- androgen insensitivity syndrome (E34.5-) (from E88)
- congenital adrenal hyperplasia (E25.0) (from E88)
- hemolytic anemias attributable to enzyme disorders (D55.-) (from E88)
- Marfan syndrome (Q87.4-) (from E88)
- 5-alpha-reductase deficiency (E29.1) (from E88)
- histiocytosis X (chronic) (C96.6) (from E88)
Excludes2
Not included here — may be reported together when both conditions exist.
Use additional code
Add a code to identify the following, if applicable.
Also known as
- Tumor lysis syndrome (spontaneous)
- Tumor lysis syndrome following antineoplastic drug chemotherapy
- Syndrome, tumor lysisNEC
- Tumor lysis syndromeNEC
Parent code
- E88Other and unspecified metabolic disordersHeader
Related codes
- E88.0Disorders of plasma-protein metabolism, not elsewhere classifiedHeader
- E88.1Lipodystrophy, not elsewhere classifiedHeader
- E88.2Lipomatosis, not elsewhere classifiedBillable
- E88.4Mitochondrial metabolism disordersHeader
- E88.8Other specified metabolic disordersHeader
- E88.9Metabolic disorder, unspecifiedBillable
- E88.AWasting disease (syndrome) due to underlying conditionBillable